Clinical Trial Update: Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating Juvista (avotermin) for preventing keloid scar formation after ear lobe removal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid

Drugs mentioned

• Juvista (avotermin)

Snippet

Sponsor: Renovo | Conditions: Keloid | Phase 1, Phase 2 | Status: COMPLETED